Strategies for antimicrobial peptide coatings on medical devices: a review and regulatory science perspective

• Published in: Critical reviews in biotechnology Vol. 41; no. 1; pp. 94 - 120
• Main Authors: Kazemzadeh-Narbat, Mehdi, Cheng, Hao, Chabok, Rosa, Alvarez, Mario Moisés, de la Fuente-Nunez, Cesar, Phillips, K. Scott, Khademhosseini, Ali
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 02.01.2021
• Subjects: antibiotics; antimicrobial peptides; antimicrobial properties; biofilm; Biomaterials; biotechnology; coatings; Food and Drug Adminstration (FDA); fungi; Gram-positive bacteria; implants; incidence; infection; injection; literature; markets; medical device; medical equipment; pathogens; regulatory science; surfaces; surgery; testing; viruses; Food and Drug Adminstration (FDA); coatings; infection; regulatory science; implants; medical device; antimicrobial peptides; Biomaterials
• ISSN: 0738-8551; 1549-7801; 1549-7801
• DOI: 10.1080/07388551.2020.1828810

Indwelling and implanted medical devices are subject to contamination by microbial pathogens during surgery, insertion or injection, and ongoing use, often resulting in severe nosocomial infections. Antimicrobial peptides (AMPs) offer a promising alternative to conventional antibiotics to reduce the incidence of such infections, as they exhibit broad-spectrum antimicrobial activity against Gram-negative and Gram-positive bacteria, microbial biofilms, fungi, and viruses. In this review-perspective, we first provide an overview of the progress made in this field over the past decade with an emphasis on the local release of AMPs from implant surfaces and immobilization strategies for incorporating these agents into a wide range of medical device materials. We then provide a regulatory science perspective addressing the characterization and testing of AMP coatings based on the type of immobilization strategy used with a focus on the US market regulatory niche. Our goal is to help narrow the gulf between academic studies and preclinical testing, as well as to support a future literature base in order to develop the regulatory science of antimicrobial coatings.